Cytokine Profiling in Ocular Disease: Diagnostic Insights and Therapeutic Opportunities
BioFactors · 2026-11 · 52 (6)
DOI: 10.1002/biof.70165 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioFactors, online erschienen am 14.11.2026. Verfasst von Yijia Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, Zhejiang, P. R. China. Hauptthemen laut MEDLINE: Cytokines, Eye Diseases. Die Arbeit nennt 180 Literaturangaben. Gefördert von: Construction Fund of Key Medical Disciplines of Hangzhou Immune Disease and Precision Medicine, Zhejiang Province Medical and Health Technology Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Ocular diseases comprise a diverse group of disorders driven by complex and heterogeneous pathogenic mechanisms, many of which remain difficult to diagnose and treat effectively. Despite advances in ophthalmic care, current therapeutic options are still limited for many conditions, and visual outcomes remain suboptimal in a substantial proportion of patients. Cytokines, which mediate intercellular communication within ocular tissues, have emerged as key regulators of inflammation, angiogenesis, immune dysregulation, fibrosis, and tissue remodeling across a wide range of eye diseases. Recent progress in cytokine detection technologies and intraocular fluid analysis has provided new opportunities to elucidate disease mechanisms, improve diagnostic precision, refine disease classification, and identify actionable therapeutic targets. In this review, we summarize advances in cytokine detection methods and discuss their clinical relevance in uveitis, primary vitreoretinal lymphoma, Fundus Neovascular Diseases (FNDs), cataract, myopia, proliferative vitreoretinopathy, and dry eye disease. We also highlight the emerging role of cytokine‐directed therapies and their potential to enable precision medicine and more personalized management in ophthalmology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou First People's Hospital, Hangzhou, Zhejiang, P. R. China.
- Department of Ophthalmology, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, P. R. China.
- Department of Ophthalmology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, P. R. China.
- Department of Ophthalmology, Mass Eye and Ear, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, P. R. China.
- Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, SAR, P. R. China.
ORCID-Profile: Yijia Zhang, Shisong Rong, Wai Kit Chu
Förderung
- Construction Fund of Key Medical Disciplines of Hangzhou Immune Disease and Precision Medicine
- Zhejiang Province Medical and Health Technology Project
- National Natural Science Foundation of China
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Xiong, J., Rong, S., Cai, J., Tao, Y., Hu, Y., Chu, W. K., & Li, J. (2026). Cytokine Profiling in Ocular Disease: Diagnostic Insights and Therapeutic Opportunities. BioFactors, 52(6). https://doi.org/10.1002/biof.70165
Vancouver
Zhang Y, Xiong J, Rong S, Cai J, Tao Y, Hu Y, et al. Cytokine Profiling in Ocular Disease: Diagnostic Insights and Therapeutic Opportunities. BioFactors. 2026;52(6). doi:10.1002/biof.70165
BibTeX
@article{Zhang2026,
author = {Zhang, Yijia and Xiong, Jiabei and Rong, Shisong and Cai, Jiayin and Tao, Yong and Hu, Yongping and Chu, Wai Kit and Li, Jian},
title = {Cytokine Profiling in Ocular Disease: Diagnostic Insights and Therapeutic Opportunities},
journal = {BioFactors},
year = {2026},
volume = {52},
number = {6},
doi = {10.1002/biof.70165}
}
EUVIMED